Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL) (C-Term) Peptid
CBL
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle CBL Produkte
- CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))
- Protein Region
- C-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- GEGNLAAAHA NTGPEESENE DDGYDVPKPP VPAVLARRTL SDISNASSSF
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- CBL Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL) peptide
CBL Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Schwein Wirt: Synthetic BP, Imm
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))
- Synonyme
- 4732447J05Rik Peptide, Cbl-2 Peptide, c-Cbl Peptide, cbl Peptide, C-CBL Peptide, CBL2 Peptide, FRA11B Peptide, NSLL Peptide, RNF55 Peptide, c-cbl-like Peptide, RGD1561386 Peptide, Casitas B-lineage lymphoma Peptide, Cbl proto-oncogene Peptide, Cbl Peptide, CBL Peptide
- Hintergrund
-
This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder.
Alias Symbols: CBL2, NSLL, C-CBL, RNF55, FRA11B
Protein Size: 906 - Gen-ID
- 867
- NCBI Accession
- NM_005188, NP_005179
- UniProt
- P22681
-
Sie sind hier:
